Trial Profile
A Study to Evaluate the Effects of Add-on Rotigotine as an Adjunctive Afternoon Dose in Parkinson's disease (PD) Patients with Stable Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 18 Dec 2015 New trial record